INFO60
SpotlightTopics60sNEWQuizLogin
IndiaAI & TechBusinessTechnologySportsEntertainmentHealthScienceWorld
INFO60

Know more. Read less. What matters, fast.

Company

  • About
  • Contact
  • Editorial Policy
  • Corrections
  • Our desks
  • Publishers

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Account

  • Delete Account
  • Spotlight
  • Quick Cards
  • Topics
  • Web Stories
  • Hindi News

Free. One email a day. Unsubscribe anytime.

Editions

  • India
  • United States
  • United Kingdom
  • Canada
  • Australia
  • UAE & Gulf
  • Singapore
  • Hindi
  • All countries
© 2026 Info60. All rights reserved.
Home›entertainment›XLOV's Wumuti To Sit Out Schedule Due To Health Concerns
entertainmentBREAKING

XLOV's Wumuti To Sit Out Schedule Due To Health Concerns

By Info60 World Desk•Summary of reporting by soompi.com•2h ago•0 views•
XLOV's Wumuti To Sit Out Schedule Due To Health Concerns
XLOV’s Wumuti will not be participating in today’s scheduled activities due to his health. On October 3, StrangeLab announced that Wumuti would be sitting
XLOV’s Wumuti will not be participating in today’s scheduled activities due to his health. On October 3, StrangeLab announced that Wumuti would be sitting
Read Full Article

Share this story

Report an error

Up next

Related Stories

October Rookie Idol Group Brand Reputation Rankings Announced

October Rookie Idol Group Brand Reputation Rankings Announced

soompi.com

5 Reasons To Watch BL "After Moving Seats, The Boy Behind Me Has A Crush On Me"

5 Reasons To Watch BL "After Moving Seats, The Boy Behind Me Has A Crush On Me"

soompi.com

"Four Hands, Two Sonatas" And "Dive Into You" Both Earn Their Highest Ratings Yet

"Four Hands, Two Sonatas" And "Dive Into You" Both Earn Their Highest Ratings Yet

soompi.com

"The Assassin(s)" Surpasses 2 Million Moviegoers

"The Assassin(s)" Surpasses 2 Million Moviegoers

soompi.com

"Music Core" And More To Not Air Today

"Music Core" And More To Not Air Today

soompi.com

Comments (0)

Please login to comment

Login
💬

No comments yet. Be the first to comment!